March 2016 – With no previous prospective studies of aggressive non-Hodgkin lymphoma treated with CHOP in sub-Saharan Africa, results of this study suggest that CHOP can be safe, effective, and feasible for treating aggressive NHL among HIV+/- individuals in Malawi.